PubMed 17125248
Referenced in: none
Automatically associated channels: Kv1.5
Title: Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
Authors: B Wesley Trotter, Kausik K Nanda, Nathan R Kett, Christopher P Regan, Joseph J Lynch, Gary L Stump, Laszlo Kiss, Jixin Wang, Robert H Spencer, Stefanie A Kane, Rebecca B White, Rena Zhang, Kenneth D Anderson, Nigel J Liverton, Charles J McIntyre, Douglas C Beshore, George D Hartman, Christopher J Dinsmore
Journal, date & volume: J. Med. Chem., 2006 Nov 30 , 49, 6954-7
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/17125248
Abstract
Novel 3-cyanoisoquinoline Kv1.5 antagonists have been prepared and evaluated in in vitro and in vivo assays for inhibition of the Kv1.5 potassium channel and its associated cardiac potassium current, IKur. Structural modifications of isoquinolinone lead 1 afforded compounds with excellent potency, selectivity, and oral bioavailability.